Osprey Medical says it raised a private placement worth about $11 million for its Avert device to prevent contrast-induced nephropathy.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CUUogB
Cap comentari:
Publica un comentari a l'entrada